Arteris, Inc. (NASDAQ:AIP) Director Sells 5,000 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) Director Wayne C. Cantwell sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $11.01, for a total transaction of $55,050.00. Following the sale, the director now directly owns 233,198 shares in the company, valued at $2,567,509.98. This trade represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Arteris Price Performance

Shares of NASDAQ AIP traded up $0.03 during mid-day trading on Monday, reaching $12.28. 495,407 shares of the company were exchanged, compared to its average volume of 869,555. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $12.64. The company’s 50 day moving average price is $9.00 and its 200 day moving average price is $8.08. The stock has a market capitalization of $493.37 million, a PE ratio of -12.79 and a beta of 1.17. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.

Hedge Funds Weigh In On Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of the company. US Bancorp DE purchased a new position in shares of Arteris during the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris during the second quarter valued at approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris during the second quarter worth approximately $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris in the 3rd quarter valued at $226,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.